Although GLP-1RAs can reduce body weight by 15%25% in controlled settings, real-world adherence is limited, and nearly 70% of patients experience weight regain after discontinuation, raising the risk of long-term pharmacological dependence ( Looking ahead, the future of GLP-1based therapy will depend on addressing safety concerns, improving long-term adherence, and expanding clinical indications
The longer you have T1D, the greater your risk for complications including heart and kidney disease nerve damage, and vision problems
-4 DPP-4 -4 .241 GLP-1(936) -
These medications slow stomach emptying as part of how they work, which helps you feel full longer and reduces appetite but can also cause: Nausea or reduced appetite Constipation, bloating, or heartburn Mild fatigue in the early weeks At Full Potential HRT Clinic, we dont just hand you a prescription and hope for the best
Monitor patients receiving JARDIANCE for signs and symptoms of diabetic foot infection (including osteomyelitis), new pain or tenderness, sores or ulcers involving the lower limbs, and institute appropriate treatment